Evidence map›Paper›PMID 37240301›Full record

ArticleInternational journal of molecular sciences2023

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.

Vicky Smith, Dave Lee, Mark Reardon, Rekaya Shabbir, Sudhakar Sahoo, Peter Hoskin, Ananya Choudhury, Timothy Illidge, Catharine M L West

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Emerging roles of MITF as a crucial regulator of immunity.Experimental & molecular medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vicky SmithDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-9336-6946
Dave LeeComputational Biology Support, CRUK Manchester Institute, Alderley Park SK10 4TG, UK.
Mark ReardonDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-5187-7038
Rekaya ShabbirDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Sudhakar SahooComputational Biology Support, CRUK Manchester Institute, Alderley Park SK10 4TG, UK.
Peter HoskinDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-8323-9567
Ananya ChoudhuryDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Timothy IllidgeDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0003-3191-7324
Catharine M L WestDivision of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
University of Manchester · GBCancer Research UK Manchester Institute · GBManchester Academic Health Science Centre · GB

Funding

Cancer Research UK MICR_CORE_COMPU _2324NIHR Manchester Biomedical Research Centre NIHR129943
6 · The paper itself

Abstract

Hypoxia and a suppressive tumour microenvironment (TME) are both independent negative prognostic factors for muscle-invasive bladder cancer (MIBC) that contribute to treatment resistance. Hypoxia has been shown to induce an immune suppressive TME by recruiting myeloid cells that inhibit anti-tumour T cell responses. Recent transcriptomic analyses show hypoxia increases suppressive and anti-tumour immune signalling and infiltrates in bladder cancer. This study sought to investigate the relationship between hypoxia-inducible factor (HIF)-1 and -2, hypoxia, and immune signalling and infiltrates in MIBC. ChIP-seq was performed to identify HIF1α, HIF2α, and HIF1β binding in the genome of the MIBC cell line T24 cultured in 1% and 0.1% oxygen for 24 h. Microarray data from four MIBC cell lines (T24, J82, UMUC3, and HT1376) cultured under 1%, 0.2%, and 0.1% oxygen for 24 h were used. Differences in the immune contexture between high- and low-hypoxia tumours were investigated using in silico analyses of two bladder cancer cohorts (BCON and TCGA) filtered to only include MIBC cases. GO and GSEA were used with the R packages "limma" and "fgsea". Immune deconvolution was performed using ImSig and TIMER algorithms. RStudio was used for all analyses. Under hypoxia, HIF1α and HIF2α bound to ~11.5-13.5% and ~4.5-7.5% of immune-related genes, respectively (1-0.1% O

Indexed as

Basic Helix-Loop-Helix ProteinsUrinary Bladder NeoplasmsHumansHypoxiaMusclesOxygenTumor MicroenvironmentBasic Helix-Loop-Helix ProteinsOxygenbladder cancerChIP-seqHIFhypoxiaICIsimmune TMEimmunotherapyMIBCTIME

Identifiers

PMID37240301
PMCPMC10219458
OpenAlexW4377108011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.